Octave Bioscience is using precision medicine to treat patients with multiple sclerosis (MS). MS is a chronic, complex and debilitating disease. Octave is striving to change this by using their MS Precision Care Solution, which complements the art of medicine with new multi-dimensional care insights. Octave accurately and objectively measures disease activity, progression and severity for better management of complex, neurodegenerative diseases. By analyzing insights, Octave has the context to help improve the MS care experience, from tracking disease activity and progression to optimizing therapy for better outcomes.

Octave Bioscience

Founded: 2013
Location: Menlo Park, CA
Employee range: 51-100
Funding: 10-100M

Short description:

Drug notes:

Long description:

Jobs: